DICER1 tumor predisposition: define the outcome before estimating risk
DICER1 links RNA processing to a distinctive tumor spectrum. For researchers, meaningful risk estimates depend on age, recruitment and whether an outcome includes benign growths.
Browse published, medically reviewed explanations. Search a gene, condition or research question, or narrow the collection by topic.
65 articles
DICER1 links RNA processing to a distinctive tumor spectrum. For researchers, meaningful risk estimates depend on age, recruitment and whether an outcome includes benign growths.
Read a KRAS G12C result: exact variant, tumour versus plasma testing, treatment context and trial outcomes, with practical examples.
An NCI research agenda highlights living-cell drug testing alongside genomics. A pediatric feasibility study shows why useful laboratory results still require stronger clinical evidence.
Understand absolute and relative risk with worked examples, odds ratios, polygenic scores and a practical worksheet for reading research.
A screen identifies candidates under particular experimental conditions; orthogonal evidence is needed before treating a hit as a disease mechanism or therapeutic target.
Read functional variant evidence critically: calibration, PS3/BS3, BRCA1 experiments and what a normal or abnormal assay can miss.
A reproducible methylation pattern can support a diagnosis, but classifier coverage and validation determine how much it can resolve.
Learn why donor numbers matter in single-cell studies, with a worked example, pseudobulk comparison and checks for confounding.
Understand when long-read sequencing may help after an inconclusive test, with examples of phase, repeat expansions and diagnostic-yield claims.
Small populations make endpoint selection more demanding, not less; connect measurement quality, natural history and patient relevance.
Assess long-term gene-therapy results using clinical outcomes, follow-up duration, missing data and additional treatments. Includes a reading worksheet.
FAIR principles and responsible governance can support discovery while preserving consent, privacy and accountability.